Fidelity Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30M Buy
546,100
+4,588
+0.8% +$252K ﹤0.01% 1564
2025
Q1
$38.3M Buy
541,512
+303,355
+127% +$21.4M ﹤0.01% 1460
2024
Q4
$15.7M Buy
238,157
+31,619
+15% +$2.08M ﹤0.01% 1800
2024
Q3
$14.5M Buy
206,538
+36,877
+22% +$2.59M ﹤0.01% 1812
2024
Q2
$14M Sell
169,661
-316,822
-65% -$26.1M ﹤0.01% 1772
2024
Q1
$42.5M Sell
486,483
-583,498
-55% -$51M ﹤0.01% 1380
2023
Q4
$103M Buy
1,069,981
+356,184
+50% +$34.3M 0.01% 995
2023
Q3
$63.2M Buy
713,797
+166,219
+30% +$14.7M 0.01% 1167
2023
Q2
$47.5M Sell
547,578
-4,071
-0.7% -$353K ﹤0.01% 1296
2023
Q1
$53.6M Buy
551,649
+86,382
+19% +$8.4M ﹤0.01% 1239
2022
Q4
$48.2M Sell
465,267
-218,745
-32% -$22.6M ﹤0.01% 1270
2022
Q3
$58M Buy
684,012
+169,732
+33% +$14.4M 0.01% 1189
2022
Q2
$42.6M Buy
514,280
+248,829
+94% +$20.6M ﹤0.01% 1339
2022
Q1
$20.5M Buy
265,451
+84,230
+46% +$6.49M ﹤0.01% 1772
2021
Q4
$16M Buy
181,221
+110,600
+157% +$9.77M ﹤0.01% 1923
2021
Q3
$5.46M Buy
70,621
+3,643
+5% +$282K ﹤0.01% 2334
2021
Q2
$5.59M Sell
66,978
-10,049
-13% -$838K ﹤0.01% 2297
2021
Q1
$5.82M Sell
77,027
-2,559
-3% -$193K ﹤0.01% 2213
2020
Q4
$6.98M Sell
79,586
-588,553
-88% -$51.6M ﹤0.01% 2087
2020
Q3
$50.8M Sell
668,139
-1,315,019
-66% -$100M 0.01% 1183
2020
Q2
$245M Buy
1,983,158
+246,834
+14% +$30.4M 0.03% 530
2020
Q1
$147M Buy
1,736,324
+1,101,071
+173% +$93M 0.02% 612
2019
Q4
$53.7M Buy
635,253
+42,371
+7% +$3.58M 0.01% 1179
2019
Q3
$40M Sell
592,882
-223,054
-27% -$15M ﹤0.01% 1274
2019
Q2
$69.9M Sell
815,936
-505,130
-38% -$43.3M 0.01% 1070
2019
Q1
$117M Buy
1,321,066
+374,021
+39% +$33.2M 0.01% 841
2018
Q4
$80.6M Sell
947,045
-353,443
-27% -$30.1M 0.01% 942
2018
Q3
$126M Sell
1,300,488
-809,816
-38% -$78.5M 0.01% 856
2018
Q2
$199M Sell
2,110,304
-2,035,754
-49% -$192M 0.02% 665
2018
Q1
$336M Sell
4,146,058
-1,824,275
-31% -$148M 0.04% 474
2017
Q4
$532M Sell
5,970,333
-2,049,058
-26% -$183M 0.06% 335
2017
Q3
$746M Sell
8,019,391
-1,276,131
-14% -$119M 0.09% 232
2017
Q2
$844M Sell
9,295,522
-407,488
-4% -$37M 0.1% 206
2017
Q1
$852M Buy
9,703,010
+812,496
+9% +$71.3M 0.11% 197
2016
Q4
$736M Sell
8,890,514
-1,189,027
-12% -$98.5M 0.1% 221
2016
Q3
$933M Sell
10,079,541
-993,804
-9% -$91.9M 0.12% 172
2016
Q2
$862M Sell
11,073,345
-2,386,118
-18% -$186M 0.12% 184
2016
Q1
$1.11B Sell
13,459,463
-1,150,376
-8% -$94.9M 0.15% 138
2015
Q4
$1.53B Sell
14,609,839
-1,979,702
-12% -$207M 0.21% 91
2015
Q3
$1.75B Buy
16,589,541
+2,730,979
+20% +$288M 0.25% 76
2015
Q2
$1.9B Buy
13,858,562
+1,975,747
+17% +$270M 0.24% 76
2015
Q1
$1.48B Sell
11,882,815
-1,548,774
-12% -$193M 0.19% 122
2014
Q4
$1.21B Buy
13,431,589
+850,778
+7% +$76.9M 0.16% 138
2014
Q3
$908M Buy
12,580,811
+3,362,794
+36% +$243M 0.12% 181
2014
Q2
$573M Buy
9,218,017
+1,919,366
+26% +$119M 0.08% 296
2014
Q1
$498M Sell
7,298,651
-495,810
-6% -$33.8M 0.07% 310
2013
Q4
$548M Sell
7,794,461
-3,895,285
-33% -$274M 0.08% 281
2013
Q3
$844M Sell
11,689,746
-697,180
-6% -$50.4M 0.13% 174
2013
Q2
$691M Buy
+12,386,926
New +$691M 0.11% 203